LifeStance Health Group, Inc.LFSTNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank50
5Y CAGR-48.9%
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

5Y CAGR
-48.9%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
202533.80-56.9%
202478.37+348.5%
2023-31.54-113.1%
2022-14.80-13.6%
2021-13.03-101.3%
2020973.12+151.4%
2019387.08-